Naratriptan Akut Al (Naratriptan)

Naratriptan works by selectively stimulating serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve fibers. This action causes constriction of dilated intracranial arteries and blocks the release of inflammatory neuropeptides, interrupting the migraine cascade and reducing pain.

The appropriate dose of naratriptan is determined by a qualified prescriber based on the individual’s medical condition, response to therapy, and any concomitant medications. Patients should follow the dosing instructions provided on the prescription label and consult their healthcare professional for any adjustments.

Safety data for naratriptan in pregnancy and lactation are limited, and the pregnancy category is listed as unknown. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this medication.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will respond with pricing, availability, shipping details, and any necessary import documentation.

Naratriptan belongs to the triptan class, which is generally more effective for moderate to severe migraine attacks than simple analgesics such as acetaminophen or ibuprofen. Compared with other triptans, naratriptan has a longer half‑life, allowing a single dose to provide sustained relief, though individual response may vary.

Naratriptan Akut Al should be stored at ambient temperature, below 25 °C. Keep the tablets in their original blister pack or container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Naratriptan Akut Al is taken orally, usually as a tablet, with or without water. It should be swallowed whole and not chewed or crushed. The medication is most effective when taken at the first sign of a migraine attack.

Serious risks include serotonin syndrome when combined with other serotonergic drugs, coronary vasospasm leading to chest pain or heart attack, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience chest discomfort, rapid heartbeat, or signs of an allergic reaction.

Naratriptan is contraindicated in individuals with a history of coronary artery disease, uncontrolled hypertension, recent myocardial infarction or stroke, and those currently taking MAO inhibitors or ergot alkaloids. It should also be avoided in patients with known hypersensitivity to naratriptan or any of its excipients.